Newstral
Article
jdsupra.com on 2017-09-08 21:44
Mylan Pharm. v. AstraZeneca AB (PTAB 2017)
Related news
- AstraZeneca AB v. Mylan Pharms. Inc.jdsupra.com
- AstraZeneca AB v. Mylan Pharms., Inc.,jdsupra.com
- AstraZeneca AB v. Mylan Pharms., Inc. Symbicort® (Budesonide and Formoterol)jdsupra.com
- Otsuka Pharm. Co., Ltd. v. Mylan Inc.jdsupra.com
- Valeant Pharm. N. Am. LLC v. Mylan Pharm. Inc.jdsupra.com
- 2019 Report: Federal Circuit Appeals from the PTAB - Summaries of Key 2018 Decisions: Saint Regis Mohawk Tribe v. Mylan Pharm. Inc., 896 F.3D 1322 (FED. CIR. 2018)jdsupra.com
- PTAB Rejects Attempts to Expand the Scope of CBM Review - Par Pharm., Inc. v. Jazz Pharm., Inc.jdsupra.com
- Twilio, Inc. v. Telesign Corp. (PTAB 2017)jdsupra.com
- AstraZeneca AB v. Apotex Corp.jdsupra.com
- Novartis Pharm. Corp. v. Noven Pharm., Inc.jdsupra.com
- Sun Pharm. Indus. v. Saptalis Pharm., LLCjdsupra.com
- Cumberland Pharmaceuticals Inc. v. Mylan Institutional LLC (Fed. Cir. 2017)jdsupra.com
- The Medicines Company v. Mylan, Inc. (Fed. Cir. 2017)jdsupra.com
- Mylan Institutional LLC v. Aurobindo Pharma Ltd. (Fed. Cir. 2017)jdsupra.com
- General Plastic Industrial Co. v. Canon Kabushiki Kaisha (PTAB 2017)jdsupra.com
- Cloud9 Technologies LLC v. IPC Systems, Inc. (PTAB 2017)jdsupra.com
- Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2020 Decisions: Amneal Pharm. LLC v. Almirall, LLC, 960 F.3d 1368 (Fed. Cir. 2020)jdsupra.com
- AstraZeneca AB v. Zydus Pharms. (USA) Inc.jdsupra.com